Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mirum Pharmaceuticals (MIRM) Prepaid Assets (2020 - 2025)

Mirum Pharmaceuticals (MIRM) has 6 years of Prepaid Assets data on record, last reported at $18.1 million in Q4 2025.

  • For Q4 2025, Prepaid Assets rose 53.94% year-over-year to $18.1 million; the TTM value through Dec 2025 reached $18.1 million, up 53.94%, while the annual FY2025 figure was $18.1 million, 53.94% up from the prior year.
  • Prepaid Assets reached $18.1 million in Q4 2025 per MIRM's latest filing, down from $23.9 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $23.9 million in Q3 2025 and bottomed at $3.8 million in Q2 2022.
  • Average Prepaid Assets over 5 years is $10.3 million, with a median of $9.4 million recorded in 2023.
  • Peak YoY movement for Prepaid Assets: dropped 16.32% in 2022, then soared 157.52% in 2023.
  • A 5-year view of Prepaid Assets shows it stood at $5.3 million in 2021, then skyrocketed by 69.74% to $8.9 million in 2022, then rose by 22.22% to $10.9 million in 2023, then rose by 7.76% to $11.8 million in 2024, then soared by 53.94% to $18.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Prepaid Assets were $18.1 million in Q4 2025, $23.9 million in Q3 2025, and $19.1 million in Q2 2025.